Utah Medical Products ROE 2006-2019 | UTMD

Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Utah Medical Products ROE for the three months ending June 30, 2019 was 15.13%.
Utah Medical Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.02B $0.09B 18.68%
2019-03-31 $0.02B $0.09B 19.26%
2018-12-31 $0.02B $0.09B 20.93%
2018-09-30 $0.01B $0.09B 14.41%
2018-06-30 $0.01B $0.08B 11.08%
2018-03-31 $0.01B $0.08B 11.29%
2017-12-31 $0.01B $0.08B 11.65%
2017-09-30 $0.02B $0.08B 20.00%
2017-06-30 $0.01B $0.08B 19.18%
2017-03-31 $0.01B $0.07B 18.18%
2016-12-31 $0.01B $0.07B 16.84%
2016-09-30 $0.01B $0.07B 16.78%
2016-06-30 $0.01B $0.07B 17.08%
2016-03-31 $0.01B $0.07B 17.27%
2015-12-31 $0.01B $0.07B 17.78%
2015-09-30 $0.01B $0.07B 18.11%
2015-06-30 $0.01B $0.07B 18.39%
2015-03-31 $0.01B $0.06B 18.60%
2014-12-31 $0.01B $0.07B 18.68%
2014-09-30 $0.01B $0.06B 18.97%
2014-06-30 $0.01B $0.07B 19.51%
2014-03-31 $0.01B $0.06B 20.51%
2013-12-31 $0.01B $0.06B 21.62%
2013-09-30 $0.01B $0.06B 20.75%
2013-06-30 $0.01B $0.05B 21.57%
2013-03-31 $0.01B $0.05B 20.30%
2012-12-31 $0.01B $0.05B 20.94%
2012-09-30 $0.01B $0.05B 22.10%
2012-06-30 $0.01B $0.05B 20.93%
2012-03-31 $0.01B $0.05B 21.69%
2011-12-31 $0.01B $0.04B 17.61%
2011-09-30 $0.01B $0.04B 17.95%
2011-06-30 $0.01B $0.04B 17.95%
2011-03-31 $0.01B $0.04B 15.48%
2010-12-31 $0.01B $0.04B 17.95%
2010-09-30 $0.01B $0.04B 17.95%
2010-06-30 $0.01B $0.04B 18.30%
2010-03-31 $0.01B $0.04B 21.33%
2009-12-31 $0.01B $0.04B 21.92%
2009-09-30 $0.01B $0.04B 22.38%
2009-06-30 $0.01B $0.04B 21.92%
2009-03-31 $0.01B $0.04B 21.33%
2008-12-31 $0.01B $0.04B 20.78%
2008-09-30 $0.01B $0.04B 20.25%
2008-06-30 $0.01B $0.04B 20.51%
2008-03-31 $0.01B $0.04B 20.92%
2007-12-31 $0.01B $0.04B 21.19%
2007-09-30 $0.01B $0.04B 21.62%
2007-06-30 $0.01B $0.04B 22.07%
2007-03-31 $0.01B $0.04B 22.54%
2006-12-31 $0.01B $0.04B 23.02%
2006-09-30 $0.01B $0.04B 23.53%
2006-06-30 $0.01B $0.03B 23.70%
2006-03-31 $0.01B $0.03B 23.70%
2005-12-31 $0.01B $0.03B 23.36%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.371B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.825B 27.79
Medtronic (MDT) Ireland $147.584B 20.72
Stryker (SYK) United States $82.482B 28.52
Boston Scientific (BSX) United States $59.759B 28.99
Baxter (BAX) United States $44.643B 27.07
EssilorLuxottica Societe Anonyme (ESLOY) France $31.425B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.623B 18.32
Coloplast (CLPBY) Denmark $25.682B 41.00
Lonza Group Ag (LZAGY) Switzerland $25.628B 0.00
Terumo (TRUMY) Japan $22.710B 26.11
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
ResMed (RMD) United States $19.048B 36.32
Sunny Optical Technology (SNPTF) China $16.288B 0.00
Bio-Rad Laboratories (BIO) United States $10.082B 54.05
Canopy Growth (CGC) Canada $10.015B 0.00
Insulet (PODD) United States $8.923B 528.71
Perrigo (PRGO) Ireland $7.527B 13.86
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.973B 20.79
Haemonetics (HAE) United States $6.488B 48.96
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.192B 0.00
Neogen (NEOG) United States $4.086B 67.83
NuVasive (NUVA) United States $3.383B 26.97
ICU Medical (ICUI) United States $3.322B 21.55
Hutchison China MediTech (HCM) China $2.766B 0.00
Quidel (QDEL) United States $2.645B 26.26
Agios Pharmaceuticals (AGIO) United States $2.144B 0.00
National Vision Holdings (EYE) United States $2.086B 45.03
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.577B 0.00
VAREX IMAGING (VREX) United States $1.099B 25.32
AtriCure (ATRC) United States $1.000B 0.00
Lantheus Holdings (LNTH) United States $0.999B 26.25
Omeros (OMER) United States $0.912B 0.00
Phibro Animal Health (PAHC) United States $0.882B 14.34
NanoString Technologies (NSTG) United States $0.807B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.793B 20.22
Cerus (CERS) United States $0.744B 0.00
PetIQ (PETQ) United States $0.740B 17.47
LeMaitre Vascular (LMAT) United States $0.710B 42.09
MacroGenics (MGNX) United States $0.631B 0.00
Surmodics (SRDX) United States $0.623B 118.46
TG Therapeutics (TGTX) United States $0.609B 0.00
Quanterix (QTRX) United States $0.598B 0.00
OraSure Technologies (OSUR) United States $0.463B 21.43
Meridian Bioscience (VIVO) United States $0.413B 12.88
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.373B 0.00
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.304B 32.28
United Health Products (UEEC) United States $0.293B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.174B 0.00
Vapotherm (VAPO) United States $0.171B 0.00
Chimerix (CMRX) United States $0.146B 0.00
Fonar (FONR) United States $0.143B 10.19
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
InfuSystems Holdings (INFU) United States $0.102B 0.00
United-Guardian (UG) United States $0.088B 20.88
MRI Interventions (MRIC) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00